LNMG — Linike Medical Cashflow Statement
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeSmall Cap
- $153.86m
- $153.86m
Annual cashflow statement for Linike Medical, fiscal year end - October 31st, USD millions except per share, conversion factor applied.
2010 October 31st | 2011 October 31st | R2012 October 31st | 2013 October 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 0.034 | -0.042 | -0.057 | -0.428 |
| Depreciation | ||||
| Changes in Working Capital | 0.009 | -0.008 | 0.057 | 0.399 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Taxes Payable | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | 0.044 | -0.048 | -0 | -0.028 |
| Capital Expenditures | -0.007 | 0 | — | — |
| Purchase of Fixed Assets | ||||
| Cash from Investing Activities | -0.007 | 0 | — | — |
| Financing Cash Flow Items | 0.004 | -0.012 | 0 | 0.016 |
| Other Financing Cash Flow | ||||
| Total Cash Dividends Paid | ||||
| Net Issuance / Retirement of Stock | ||||
| Cash from Financing Activities | 0.004 | 0.107 | 0.002 | 0.016 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0.041 | 0.058 | 0.002 | 0.001 |